Global Sphingosine-1-Receptor Modulators Drugs Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Sphingosine-1-Receptor Modulators Drugs will have significant change from previous year. By the most conservative estimates of global Sphingosine-1-Receptor Modulators Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Sphingosine-1-Receptor Modulators Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Sphingosine-1-Receptor Modulators Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Sphingosine-1-Receptor Modulators Drugs, covering the supply chain analysis, impact assessment to the Sphingosine-1-Receptor Modulators Drugs market size growth rate in several scenarios, and the measures to be undertaken by Sphingosine-1-Receptor Modulators Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Fingolimod
Siponimod
Ozanimod
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Bristol-Myers Squibb
Arena Pharmaceuticals
Idorsia
Johnson & Johnson
HEC Pharm Co. Limited
Sun Pharma
Biocon
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Sphingosine-1-Receptor Modulators Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Sphingosine-1-Receptor Modulators Drugs market by identifying its various subsegments.
Focuses on the key global Sphingosine-1-Receptor Modulators Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sphingosine-1-Receptor Modulators Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Sphingosine-1-Receptor Modulators Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Sphingosine-1-Receptor Modulators Drugs?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Sphingosine-1-Receptor Modulators Drugs Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sphingosine-1-Receptor Modulators Drugs Consumption 2015-2025
2.1.2 Sphingosine-1-Receptor Modulators Drugs Consumption CAGR by Region
2.2 Sphingosine-1-Receptor Modulators Drugs Segment by Type
2.2.1 Fingolimod
2.2.2 Siponimod
2.2.3 Ozanimod
2.2.4 Other
2.3 Sphingosine-1-Receptor Modulators Drugs Consumption by Type
2.3.1 Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Type (2015-2020)
2.4 Sphingosine-1-Receptor Modulators Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Sphingosine-1-Receptor Modulators Drugs Consumption by Application
2.5.1 Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Sphingosine-1-Receptor Modulators Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Type (2015-2020)
3 Global Sphingosine-1-Receptor Modulators Drugs by Company
3.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company
3.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Company (2018-2020)
3.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company (2018-2020)
3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company
3.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Company (2018-2020)
3.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Company
3.4 Global Sphingosine-1-Receptor Modulators Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Sphingosine-1-Receptor Modulators Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Sphingosine-1-Receptor Modulators Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Sphingosine-1-Receptor Modulators Drugs by Regions
4.1 Sphingosine-1-Receptor Modulators Drugs by Regions
4.2 Americas Sphingosine-1-Receptor Modulators Drugs Consumption Growth
4.3 APAC Sphingosine-1-Receptor Modulators Drugs Consumption Growth
4.4 Europe Sphingosine-1-Receptor Modulators Drugs Consumption Growth
4.5 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption Growth
5 Americas
5.1 Americas Sphingosine-1-Receptor Modulators Drugs Consumption by Countries
5.1.1 Americas Sphingosine-1-Receptor Modulators Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Sphingosine-1-Receptor Modulators Drugs Value by Countries (2015-2020)
5.2 Americas Sphingosine-1-Receptor Modulators Drugs Consumption by Type
5.3 Americas Sphingosine-1-Receptor Modulators Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Sphingosine-1-Receptor Modulators Drugs Consumption by Regions
6.1.1 APAC Sphingosine-1-Receptor Modulators Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Sphingosine-1-Receptor Modulators Drugs Value by Regions (2015-2020)
6.2 APAC Sphingosine-1-Receptor Modulators Drugs Consumption by Type
6.3 APAC Sphingosine-1-Receptor Modulators Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Sphingosine-1-Receptor Modulators Drugs by Countries
7.1.1 Europe Sphingosine-1-Receptor Modulators Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Sphingosine-1-Receptor Modulators Drugs Value by Countries (2015-2020)
7.2 Europe Sphingosine-1-Receptor Modulators Drugs Consumption by Type
7.3 Europe Sphingosine-1-Receptor Modulators Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs by Countries
8.1.1 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption by Type
8.3 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sphingosine-1-Receptor Modulators Drugs Distributors
10.3 Sphingosine-1-Receptor Modulators Drugs Customer
11 Global Sphingosine-1-Receptor Modulators Drugs Market Forecast
11.1 Global Sphingosine-1-Receptor Modulators Drugs Consumption Forecast (2021-2025)
11.2 Global Sphingosine-1-Receptor Modulators Drugs Forecast by Regions
11.2.1 Global Sphingosine-1-Receptor Modulators Drugs Forecast by Regions (2021-2025)
11.2.2 Global Sphingosine-1-Receptor Modulators Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Sphingosine-1-Receptor Modulators Drugs Forecast by Type
11.8 Global Sphingosine-1-Receptor Modulators Drugs Forecast by Application
12 Key Players Analysis
12.1 Novartis
12.1.1 Company Information
12.1.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Bristol-Myers Squibb
12.2.1 Company Information
12.2.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Bristol-Myers Squibb Latest Developments
12.3 Arena Pharmaceuticals
12.3.1 Company Information
12.3.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.3.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Arena Pharmaceuticals Latest Developments
12.4 Idorsia
12.4.1 Company Information
12.4.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.4.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Idorsia Latest Developments
12.5 Johnson & Johnson
12.5.1 Company Information
12.5.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.5.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson Latest Developments
12.6 HEC Pharm Co. Limited
12.6.1 Company Information
12.6.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.6.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 HEC Pharm Co. Limited Latest Developments
12.7 Sun Pharma
12.7.1 Company Information
12.7.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.7.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sun Pharma Latest Developments
12.8 Biocon
12.8.1 Company Information
12.8.2 Sphingosine-1-Receptor Modulators Drugs Product Offered
12.8.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Biocon Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Sphingosine-1-Receptor Modulators Drugs Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Sphingosine-1-Receptor Modulators Drugs Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Sphingosine-1-Receptor Modulators Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Fingolimod
Table 7. Major Players of Siponimod
Table 8. Major Players of Ozanimod
Table 9. Major Players of Other
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
Table 12. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2015-2020) ($ million)
Table 13. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application (2015-2020)
Table 17. Global Sphingosine-1-Receptor Modulators Drugs Value by Application (2015-2020)
Table 18. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share by Application (2015-2020)
Table 19. Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Application (2015-2020)
Table 20. Global Sphingosine-1-Receptor Modulators Drugs Sales by Company (2017-2019) (K Units)
Table 21. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company (2017-2019)
Table 22. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company (2017-2019)
Table 24. Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Company (2017-2019)
Table 25. Global Sphingosine-1-Receptor Modulators Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Sphingosine-1-Receptor Modulators Drugs Products Offered
Table 27. Sphingosine-1-Receptor Modulators Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Sphingosine-1-Receptor Modulators Drugs Consumption by Regions 2015-2020 (K Units)
Table 29. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Regions 2015-2020
Table 30. Global Sphingosine-1-Receptor Modulators Drugs Value by Regions 2015-2020 ($ Millions)
Table 31. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share by Regions 2015-2020
Table 32. Americas Sphingosine-1-Receptor Modulators Drugs Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries (2015-2020)
Table 34. Americas Sphingosine-1-Receptor Modulators Drugs Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Sphingosine-1-Receptor Modulators Drugs Value Market Share by Countries (2015-2020)
Table 36. Americas Sphingosine-1-Receptor Modulators Drugs Consumption by Type (2015-2020) (K Units)
Table 37. Americas Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
Table 38. Americas Sphingosine-1-Receptor Modulators Drugs Consumption by Application (2015-2020) (K Units)
Table 39. Americas Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application (2015-2020)
Table 40. APAC Sphingosine-1-Receptor Modulators Drugs Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries (2015-2020)
Table 42. APAC Sphingosine-1-Receptor Modulators Drugs Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Sphingosine-1-Receptor Modulators Drugs Value Market Share by Regions (2015-2020)
Table 44. APAC Sphingosine-1-Receptor Modulators Drugs Consumption by Type (2015-2020) (K Units)
Table 45. APAC Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
Table 46. APAC Sphingosine-1-Receptor Modulators Drugs Consumption by Application (2015-2020) (K Units)
Table 47. APAC Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application (2015-2020)
Table 48. Europe Sphingosine-1-Receptor Modulators Drugs Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries (2015-2020)
Table 50. Europe Sphingosine-1-Receptor Modulators Drugs Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Sphingosine-1-Receptor Modulators Drugs Value Market Share by Countries (2015-2020)
Table 52. Europe Sphingosine-1-Receptor Modulators Drugs Consumption by Type (2015-2020) (K Units)
Table 53. Europe Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
Table 54. Europe Sphingosine-1-Receptor Modulators Drugs Consumption by Application (2015-2020) (K Units)
Table 55. Europe Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application (2015-2020)
Table 64. Sphingosine-1-Receptor Modulators Drugs Distributors List
Table 65. Sphingosine-1-Receptor Modulators Drugs Customer List
Table 66. Global Sphingosine-1-Receptor Modulators Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Forecast by Regions
Table 68. Global Sphingosine-1-Receptor Modulators Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share Forecast by Regions
Table 70. Global Sphingosine-1-Receptor Modulators Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Sphingosine-1-Receptor Modulators Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share Forecast by Type (2021-2025)
Table 74. Global Sphingosine-1-Receptor Modulators Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Sphingosine-1-Receptor Modulators Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share Forecast by Application (2021-2025)
Table 78. Novartis Product Offered
Table 79. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Novartis Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Bristol-Myers Squibb Product Offered
Table 84. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Bristol-Myers Squibb Main Business
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Arena Pharmaceuticals Product Offered
Table 89. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Arena Pharmaceuticals Main Business
Table 91. Arena Pharmaceuticals Latest Developments
Table 92. Arena Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Idorsia Product Offered
Table 94. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Idorsia Main Business
Table 96. Idorsia Latest Developments
Table 97. Idorsia Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson & Johnson Product Offered
Table 99. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. Johnson & Johnson Main Business
Table 101. Johnson & Johnson Latest Developments
Table 102. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. HEC Pharm Co. Limited Product Offered
Table 104. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. HEC Pharm Co. Limited Main Business
Table 106. HEC Pharm Co. Limited Latest Developments
Table 107. HEC Pharm Co. Limited Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharma Product Offered
Table 109. Sun Pharma Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Sun Pharma Main Business
Table 111. Sun Pharma Latest Developments
Table 112. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Biocon Product Offered
Table 114. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. Biocon Main Business
Table 116. Biocon Latest Developments
Table 117. Biocon Basic Information, Company Total Revenue (in $ million), Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Sphingosine-1-Receptor Modulators Drugs
Figure 2. Sphingosine-1-Receptor Modulators Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Sphingosine-1-Receptor Modulators Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Sphingosine-1-Receptor Modulators Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Fingolimod
Figure 7. Product Picture of Siponimod
Figure 8. Product Picture of Ozanimod
Figure 9. Product Picture of Other
Figure 10. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type (2015-2020)
Figure 11. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share by Type (2015-2020)
Figure 12. Sphingosine-1-Receptor Modulators Drugs Consumed in Hospital
Figure 13. Global Sphingosine-1-Receptor Modulators Drugs Market: Hospital (2015-2020) (K Units)
Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Market: Hospital (2015-2020) ($ Millions)
Figure 15. Sphingosine-1-Receptor Modulators Drugs Consumed in Clinic
Figure 16. Global Sphingosine-1-Receptor Modulators Drugs Market: Clinic (2015-2020) (K Units)
Figure 17. Global Sphingosine-1-Receptor Modulators Drugs Market: Clinic (2015-2020) ($ Millions)
Figure 18. Sphingosine-1-Receptor Modulators Drugs Consumed in Other
Figure 19. Global Sphingosine-1-Receptor Modulators Drugs Market: Other (2015-2020) (K Units)
Figure 20. Global Sphingosine-1-Receptor Modulators Drugs Market: Other (2015-2020) ($ Millions)
Figure 21. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application (2015-2020)
Figure 22. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share by Application (2015-2020)
Figure 23. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company in 2017
Figure 24. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company in 2019
Figure 25. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company in 2017
Figure 26. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company in 2019
Figure 27. Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Company in 2019
Figure 28. Global Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Regions 2015-2020
Figure 29. Global Sphingosine-1-Receptor Modulators Drugs Value Market Share by Regions 2015-2020
Figure 30. Americas Sphingosine-1-Receptor Modulators Drugs Consumption 2015-2020 (K Units)
Figure 31. Americas Sphingosine-1-Receptor Modulators Drugs Value 2015-2020 ($ Millions)
Figure 32. APAC Sphingosine-1-Receptor Modulators Drugs Consumption 2015-2020 (K Units)
Figure 33. APAC Sphingosine-1-Receptor Modulators Drugs Value 2015-2020 ($ Millions)
Figure 34. Europe Sphingosine-1-Receptor Modulators Drugs Consumption 2015-2020 (K Units)
Figure 35. Europe Sphingosine-1-Receptor Modulators Drugs Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Value 2015-2020 ($ Millions)
Figure 38. Americas Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries in 2019
Figure 39. Americas Sphingosine-1-Receptor Modulators Drugs Value Market Share by Countries in 2019
Figure 40. Americas Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type in 2019
Figure 41. Americas Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application in 2019
Figure 42. United States Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 43. United States Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries in 2019
Figure 49. APAC Sphingosine-1-Receptor Modulators Drugs Value Market Share by Regions in 2019
Figure 50. APAC Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type in 2019
Figure 51. APAC Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application in 2019
Figure 52. China Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 53. China Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. India Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. India Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries in 2019
Figure 65. Europe Sphingosine-1-Receptor Modulators Drugs Value Market Share by Countries in 2019
Figure 66. Europe Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type in 2019
Figure 67. Europe Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application in 2019
Figure 68. Germany Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. France Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 71. France Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. UK Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 73. UK Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption Market Share by Application in 2019
Figure 82. Egypt Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Sphingosine-1-Receptor Modulators Drugs Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Sphingosine-1-Receptor Modulators Drugs Value Growth 2015-2020 ($ Millions)
Figure 92. Global Sphingosine-1-Receptor Modulators Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Sphingosine-1-Receptor Modulators Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 95. Americas Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 96. APAC Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 97. APAC Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 98. Europe Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 99. Europe Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 102. United States Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 103. United States Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 104. Canada Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 105. Canada Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 106. Mexico Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 107. Mexico Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 108. Brazil Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 109. Brazil Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 110. China Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 111. China Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 112. Japan Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 113. Japan Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 114. Korea Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 115. Korea Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 118. India Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 119. India Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 120. Australia Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 121. Australia Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 122. Germany Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 123. Germany Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 124. France Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 125. France Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 126. UK Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 127. UK Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 128. Italy Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 129. Italy Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 130. Russia Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 131. Russia Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 132. Spain Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 133. Spain Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 134. Egypt Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 135. Egypt Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 136. South Africa Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 137. South Africa Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 138. Israel Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 139. Israel Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 140. Turkey Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 141. Turkey Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Sphingosine-1-Receptor Modulators Drugs Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Sphingosine-1-Receptor Modulators Drugs Value 2021-2025 ($ Millions)
Figure 144. Novartis Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
Figure 145. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
Figure 146. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
Figure 147. Idorsia Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
Figure 148. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
Figure 149. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
Figure 150. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
Figure 151. Biocon Sphingosine-1-Receptor Modulators Drugs Market Share (2018-2020)
